SANDER DALE A. (CFO & CCDO) purchased 97.1% of their position (20K shares) of HUMACYTE, INC. on the open market
Open‑market purchase worth $30.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/14/2025ACC: 0001818382-25-000050
+20K
Net shares
Net buyer
$30.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+20K
Price / share
$1.53
Trade value
$30.60K
% of position
97.1%
4/10/2025
20.60K→40.60K
Total
Net shares
+20K
Net value
$30.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/10/2025 | P · Purchase | +20K | $1.53 | $30.60K | 97.1% | 20.60K | 40.60K |
| Total | +20K | $30.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned2K
Total
2K direct2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Direct |
| Total | 2K | 2K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported